|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2009-11-9
|
|
pubmed:abstractText |
Menopausal hormone therapy (MHT) is a well-established factor in endometrial carcinogenesis, and therefore, could have prognostic implications. We investigated the effects of ever use of MHT on tumour grade and depth of myometrial invasion and 5-year relative survival in postmenopausal endometrial cancer patients.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1879-0852
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3064-73
|
|
pubmed:dateRevised |
2011-5-4
|
|
pubmed:meshHeading |
pubmed-meshheading:19493676-Adenocarcinoma,
pubmed-meshheading:19493676-Age Factors,
pubmed-meshheading:19493676-Aged,
pubmed-meshheading:19493676-Endometrial Neoplasms,
pubmed-meshheading:19493676-Epidemiologic Methods,
pubmed-meshheading:19493676-Estradiol Congeners,
pubmed-meshheading:19493676-Estrogen Replacement Therapy,
pubmed-meshheading:19493676-Female,
pubmed-meshheading:19493676-Humans,
pubmed-meshheading:19493676-Middle Aged,
pubmed-meshheading:19493676-Myometrium,
pubmed-meshheading:19493676-Neoplasm Invasiveness,
pubmed-meshheading:19493676-Postmenopause,
pubmed-meshheading:19493676-Progesterone Congeners,
pubmed-meshheading:19493676-Prognosis,
pubmed-meshheading:19493676-Sweden
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.
|
|
pubmed:affiliation |
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, SE-17177 Stockholm, Sweden. cco4@le.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
